McDermott and Bull executive Search

Other News

Cerus Endovascular Receives CE Mark Approval for its Contour Neurovascular System™, Designed to Treat Intracranial Aneurysms

Commercial Sales Across European Union Expected to Begin in Second Quarter of 2020 FREMONT, Calif. and OXFORD, England, Feb. 18, 2020 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its lead product, the Contour Neurovascular System™, for the treatment of […]

The Latest in Pediatric Heart Disease: Benefits of Skin-to-Skin Care, Nurse-Initiated PIV Training and Improving Cholesterol Screening in High-Risk Patients

–CHOP’s Cardiology 2020 Conference Research Highlights– PHILADELPHIA, Feb. 17, 2020 /PRNewswire/ — Experts in pediatric heart disease from across the country shared the latest findings from their research at a large national conference hosted by the Cardiac Center at Children’s Hospital of Philadelphia (CHOP). The 23rd Annual Update on Pediatric and Congenital Cardiovascular Disease, “Vision 20/20: Lessons from […]

The Biobeat Wearable Wristwatch and Patch Receive CE Mark Approval for Non-invasive Cuffless Monitoring of Blood Pressure, as Well as Cardiac Output, Stroke Volume, Pulse and Saturation

TEL AVIV, Israel, Feb. 18, 2020 /PRNewswire/ — Biobeat, a bio-medical technology company developing advanced sensing and remote monitoring solutions for patients, received CE Mark approval for its patch and wristwatch for measurement of blood pressure, cardiac output, stroke volume, blood oxygenation and heart rate in hospitals, clinics, long-term care and at home. […]

Acutus Medical Secures FDA Clearance, CE Mark for SuperMap™ and Announces First Procedures in U.S. and Initial Experience in EU

Breakthrough Technology Enables Super-Fast Electrical Mapping and Re-Mapping of the Entire Heart Chamber – Leading to Rapid, Efficient and Individualized Ablation Strategies CARLSBAD, Calif., Feb. 18, 2020 /PRNewswire/ — Acutus Medical today announced FDA clearance and CE Mark of SuperMap – a revolutionary addition to its AcQMap 3D Imaging and Mapping System. SuperMap is […]

Endotronix Announces Enrollment of the First Patients in the PROACTIVE-HF Pivotal Trial

Study to support U.S. FDA approval of the Cordella™ Pulmonary Artery Pressure Sensor System for the treatment of patients with chronic heart failure LISLE, Ill., Feb. 18, 2020 /PRNewswire/ — Endotronix, a digital health and medical technology company dedicated to advancing the treatment of chronic heart failure (HF), today announced the enrollment of […]

Published Real-World Experience Demonstrates VasQ™ External Support Improves Outcomes When Adopted as the Standard of Care

TEL AVIV, Israel, Feb. 18, 2020 /PRNewswire/ — Dr. Robert Shahverdyan, Head of Vascular Access Center at Asklepios Klinik Barmbek of Hamburg, Germany, has recently published a retrospective analysis of his first 32 consecutive radiocephalic (forearm) VasQ™ External Support procedures in the Journal of Vascular Access.  VasQ™ External Support, a Laminate Medical technology, is implanted […]

First patient enrolled in the new clinical study FILTER-SCAD targeting 2,000 patients

Press release Malmö, Sweden February 18, 2020 First patient enrolled in the new clinical study FILTER-SCAD targeting 2,000 patients Acarix AB (publ) today announced the initiation of the randomized, multi-center clinical study FILTER-SCAD to examine the cost effectiveness and safety of adding the CADScor®System as a rule-out test in patients referred with symptoms […]

Biotricity Posts Calendar Q4 Results that Show Continued Growth

REDWOOD CITY, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced calendar fourth quarter financial results for the three months which ended December 31, 2019. FOURTH QUARTER HIGHLIGHTS Revenues for the three months which ended December 31, 2019 grew by 225% […]